4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid

C45H60N2O8 — CID 71678706

About 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid

4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid (PubChem CID 71678706) has the molecular formula C45H60N2O8 and a molecular weight of 756.98 g/mol. Its IUPAC name is 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid.

Molecular Properties

• Compound Name: 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid
• PubChem CID: 71678706
• Molecular Formula: C45H60N2O8
• Molecular Weight: 756.98 g/mol
• Exact Mass: 756.43
• IUPAC Name: 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid
• SMILES: CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(Cc2nnc(-c3ccc(C(=O)O)cc3)o2)CC1=O
• InChI: InChI=1S/C45H60N2O8/c1-25(2)35-29(48)22-45(23-33-46-47-37(55-33)26-10-12-27(13-11-26)38(50)51)21-20-43(8)28(36(35)45)14-15-31-42(7)18-17-32(54-34(49)24-40(3,4)39(52)53)41(5,6)30(42)16-19-44(31,43)9/h10-13,25,28,30-32H,14-24H2,1-9H3,(H,50,51)(H,52,53)/t28-,30+,31-,32+,42+,43-,44-,45+/m1/s1
• InChIKey: SDHTZUKLZVETPZ-FIQJATNTSA-N
• XLogP: 9.37
• TPSA: 156.89 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 8
• Rotatable Bonds: 9
• Heavy Atoms: 55
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	756.98
LogP ≤ 5	9.37
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	8

Frequently Asked Questions

What is the IUPAC name of 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid?

The IUPAC name of 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid (CID 71678706) is 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid.

What is the SMILES notation for 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid?

The canonical SMILES for 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid is CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(Cc2nnc(-c3ccc(C(=O)O)cc3)o2)CC1=O.

What is the InChIKey of 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid?

The InChIKey is SDHTZUKLZVETPZ-FIQJATNTSA-N. The full InChI is InChI=1S/C45H60N2O8/c1-25(2)35-29(48)22-45(23-33-46-47-37(55-33)26-10-12-27(13-11-26)38(50)51)21-20-43(8)28(36(35)45)14-15-31-42(7)18-17-32(54-34(49)24-40(3,4)39(52)53)41(5,6)30(42)16-19-44(31,43)9/h10-13,25,28,30-32H,14-24H2,1-9H3,(H,50,51)(H,52,53)/t28-,30+,31-,32+,42+,43-,44-,45+/m1/s1.

What are the key properties of 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid?

4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid has a molecular weight of 756.98 g/mol, XLogP of 9.37, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid is sourced from PubChem (CID 71678706), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).